Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2022 07:05 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022

BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for...
August 04, 2022 10:16 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City

BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its...
July 29, 2022 07:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference

BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will...
July 14, 2022 07:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022

BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the...
May 10, 2022 07:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022

BOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first...
April 27, 2022 07:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference

BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming...
April 13, 2022 07:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022

BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for...
March 15, 2022 07:02 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results

Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed BOSTON and LAUSANNE, Switzerland, March 15, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a...
March 04, 2022 08:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference

BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr....
February 16, 2022 07:00 ET | Source: SOPHiA GENETICS, Inc.

SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right